Transcept Pharmaceuticals (TSPT)

Add to Watchlists
Create an Alert
2.95 +0.02  +0.68% NASDAQ Apr 16, 5:01PM BATS Real time Currency in USD
View Full Chart
TSPT Price Chart
View All Events

TSPT Events

Date Type Description
Mar 13 Earnings Transcept Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.22.
Mar 13 Misc Transcept Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
Dec 19 Misc SGM Event for Transcept Pharmaceuticals Inc
Nov 07 Misc Transcept Third Quarter 2013 Earnings Conference Call
Nov 07 Earnings Transcept Third Quarter 2013 Earnings Results. Estimate: -0.20.
Aug 07 Misc Transcept Pharmaceuticals to Report Second Quarter 2013 Financial Results and Host Conference Call on August 7, 2013
Aug 07 Earnings Second Quarter 2013 Financial Results. Estimate: -0.28.
May 08 Misc Transcept First Quarter 2013 Earnings Conference Call
May 08 Earnings Transcept First Quarter 2013 Earnings Conference Call and Results. Estimate: -0.42.
View All Performance Charts

TSPT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Transcept Pharmaceuticals is down 29.43% over the last year vs S&P 500 Total Return up 22.52%, Vertex Pharmaceuticals up 19.09%, and Cleveland BioLabs down 66.50%.

Get Quote for

Pro Strategies Featuring TSPT

Did Transcept Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

TSPT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience.

Recent Quotes

Symbol Price Chg Chg % Market Cap
TSPT 2.95 +0.02 +0.68% 55.59M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.